Gilead Sciences' Q1 earnings and sales miss estimates on lower oncology drug sales. The stock is trading down.

The i30N is unadulterated fun which has injected performance into the otherwise family-friendly portfolio. It’s paved the way ...

Ithaka's Q1 2025 portfolio performance lagged the R1000G. Who were the top performers and detractors? Click here to find out.

Elite businesses could turn a single investment into a retirement fortune. Find out why BN, BRK.A, and BRK.B stocks are my ...

By analysing a digital model of the roof using a wealth of data, property owners can make far more informed decisions about ...

Warren Buffett, widely regarded as one of the greatest investors of all time, has led Berkshire Hathaway (NYSE: BRK.B) for ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported in Q1 CY2025, but sales fell by 5.6% year on year to $11.2 ...

Thank you Western Herald for five years, 152 bylines, and an immeasurable amount of fulfillment.

Alongside his leadership of MAS, Schassler also serves as portfolio manager for VanEck’s asset allocation strategies and model portfolios. His expertise lies at the intersection of quantitative ...

As investor appetites for more complex asset classes increase and model portfolios evolve to offer ... select BlackRock Affiliated Funds and (b) select BlackRock Affiliated Funds with higher ...

The analysis, which covered 17 model portfolios from 14 fiduciary managers, found that all portfolios produced a positive net return during 2024. However, the model growth portfolios submitted by ...